Evidence map›Paper›PMID 28932197›Full record

ArticleFrontiers in pharmacology2017

Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles.

Zulaikha A Busari, Kabiru A Dauda, Olajumoke A Morenikeji, Funmilayo Afolayan, Oyetunde T Oyeyemi, Jairam Meena, Debasis Sahu, Amulya K Panda

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Current State of Scientific Knowledge on Curcumin Encapsulation and Applications.Recent advances in food, nutrition & agriculture · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.European journal of drug metabolism and pharmacokinetics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Zulaikha A BusariDepartment of Zoology, University of IbadanIbadan, Nigeria.
Kabiru A DaudaDepartment of Zoology, University of IbadanIbadan, Nigeria.
Olajumoke A MorenikejiDepartment of Zoology, University of IbadanIbadan, Nigeria.
Funmilayo AfolayanDepartment of Zoology, University of IbadanIbadan, Nigeria.
Oyetunde T OyeyemiDepartment of Biological Sciences, University of Medical SciencesOndo, Nigeria.
Jairam MeenaProduct Development Cell, National Institute of ImmunologyNew Delhi, India.
Debasis SahuProduct Development Cell, National Institute of ImmunologyNew Delhi, India.
Amulya K PandaProduct Development Cell, National Institute of ImmunologyNew Delhi, India.
University of Ibadan · NGNational Institute of Immunology · INLovely Professional University · INOndo State University of Science and Technology · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin is a polyphenolic pigment isolated from the rhizomes of

Indexed as

antimalarialcurcuminpolymeric nanoparticlessafety

Identifiers

PMID28932197
PMCPMC5592277
OpenAlexW2751699552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.